Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline. [electronic resource]
Producer: 20130211Description: 1812-9 p. digitalISSN:- 1546-170X
- Alzheimer Disease -- pathology
- Amyloid beta-Peptides -- metabolism
- Analysis of Variance
- Animals
- Antibodies -- administration & dosage
- Blotting, Western
- Cognition -- drug effects
- DNA Primers -- genetics
- Enzyme-Linked Immunosorbent Assay
- Flow Cytometry
- Injections, Intraperitoneal
- Interleukin-12 -- genetics
- Interleukin-12 Subunit p40 -- cerebrospinal fluid
- Mice
- Mice, Transgenic
- Microglia -- metabolism
- Real-Time Polymerase Chain Reaction
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.